136 related articles for article (PubMed ID: 36752705)
1. Profile of psychotropic agents used in autism spectrum disorder according to comorbidities in Turkey: A 4-year evaluation.
Karabacak Y; Barun S; Vural İM; Vural E; Iseri E; Kahve AC; Yilmaz EŞ; Isli F; Turkes S; Ezber E; Paykal G
Int Clin Psychopharmacol; 2023 Jul; 38(4):216-222. PubMed ID: 36752705
[TBL] [Abstract][Full Text] [Related]
2. Psychotropic Medication Prescribing for Neuropsychiatric Comorbidities in Individuals Diagnosed with Autism Spectrum Disorder (ASD) in the UK.
Alfageh BH; Man KKC; Besag FMC; Alhawassi TM; Wong ICK; Brauer R
J Autism Dev Disord; 2020 Feb; 50(2):625-633. PubMed ID: 31724119
[TBL] [Abstract][Full Text] [Related]
3. Multimorbidity and psychotropic polypharmacy among participants with autism spectrum disorder with intellectual disability.
Espadas C; Ballester P; Londoño AC; Almenara S; Aguilar V; Belda C; Pérez E; Peiró AM
Psychiatry Res; 2020 Oct; 292():113321. PubMed ID: 32738553
[TBL] [Abstract][Full Text] [Related]
4. Psychopharmacological treatment in children and adolescents with autism spectrum disorders in Germany.
Bachmann CJ; Manthey T; Kamp-Becker I; Glaeske G; Hoffmann F
Res Dev Disabil; 2013 Sep; 34(9):2551-63. PubMed ID: 23747941
[TBL] [Abstract][Full Text] [Related]
5. Psychiatric Comorbidities and Psychotropic Medication Use in Autism: A Matched Cohort Study with ADHD and General Population Comparator Groups in the United Kingdom.
Houghton R; Liu C; Bolognani F
Autism Res; 2018 Dec; 11(12):1690-1700. PubMed ID: 30380202
[TBL] [Abstract][Full Text] [Related]
6. Prevalence and predictors of psychotropic medication use in adolescents and adults with autism spectrum disorder in Italy: A cross-sectional study.
Fusar-Poli L; Brondino N; Rocchetti M; Petrosino B; Arillotta D; Damiani S; Provenzani U; Petrosino C; Aguglia E; Politi P
Psychiatry Res; 2019 Jun; 276():203-209. PubMed ID: 31102885
[TBL] [Abstract][Full Text] [Related]
7. Psychotropic Medication Use among Insured Children with Autism Spectrum Disorder.
Madden JM; Lakoma MD; Lynch FL; Rusinak D; Owen-Smith AA; Coleman KJ; Quinn VP; Yau VM; Qian YX; Croen LA
J Autism Dev Disord; 2017 Jan; 47(1):144-154. PubMed ID: 27817163
[TBL] [Abstract][Full Text] [Related]
8. Characteristics Associated with Drug Prescription and Compliance Among Young Children with Autism Spectrum Disorder.
Meiri G; Azoulay H; Menashe I
J Child Adolesc Psychopharmacol; 2018 Apr; 28(3):232-237. PubMed ID: 29266976
[TBL] [Abstract][Full Text] [Related]
9. Risk of Substance Use Disorder and Its Associations With Comorbidities and Psychotropic Agents in Patients With Autism.
Huang JS; Yang FC; Chien WC; Yeh TC; Chung CH; Tsai CK; Tsai SJ; Yang SS; Tzeng NS; Chen MH; Liang CS
JAMA Pediatr; 2021 Feb; 175(2):e205371. PubMed ID: 33394019
[TBL] [Abstract][Full Text] [Related]
10. Factors Associated with Developmental Behavioral Pediatricians Prescribing Psychotropic Medication to Children with Autism Spectrum Disorder: A Study of Three DBPNet Sites.
Jackel C; Shults J; Wiley S; Meinzen-Derr J; Augustyn M; Blum N
J Dev Behav Pediatr; 2017 Oct; 38(8):584-592. PubMed ID: 28816917
[TBL] [Abstract][Full Text] [Related]
11. Psychiatric comorbidities and use of psychotropic medications in people with autism spectrum disorder in the United States.
Houghton R; Ong RC; Bolognani F
Autism Res; 2017 Dec; 10(12):2037-2047. PubMed ID: 28963809
[TBL] [Abstract][Full Text] [Related]
12. Autism spectrum disorders and their treatment with psychotropic medications in a nationally representative outpatient sample: 1994-2009.
Kamimura-Nishimura K; Froehlich T; Chirdkiatgumchai V; Adams R; Fredstrom B; Manning P
Ann Epidemiol; 2017 Jul; 27(7):448-453.e1. PubMed ID: 28789776
[TBL] [Abstract][Full Text] [Related]
13. Use of Psychotropic Drugs among Children and Adolescents with Autism Spectrum Disorders in Denmark: A Nationwide Drug Utilization Study.
Rasmussen L; Bilenberg N; Thomsen Ernst M; Abitz Boysen S; Pottegård A
J Clin Med; 2018 Oct; 7(10):. PubMed ID: 30308952
[TBL] [Abstract][Full Text] [Related]
14. Pharmacological management of behavioral disturbances in children and adolescents with autism spectrum disorders.
Lamy M; Erickson CA
Curr Probl Pediatr Adolesc Health Care; 2018 Oct; 48(10):250-264. PubMed ID: 30262163
[TBL] [Abstract][Full Text] [Related]
15. Psychotropic Medication Use for Adults with Autism Spectrum Disorder who Receive Services and Supports Through Adult Developmental Disability Services in the United States.
Esler A; Hewitt A; Hall-Lande J; Pettingell SL; Houseworth J
J Autism Dev Disord; 2019 Jun; 49(6):2291-2303. PubMed ID: 30706350
[TBL] [Abstract][Full Text] [Related]
16. Prevalence of Psychotropic Medicine Use in Australian Children with Autism Spectrum Disorder: A Drug Utilization Study Based on Children Enrolled in the Longitudinal Study of Australian Children.
Rasmussen L; Pratt N; Roughead E; Moffat A
J Autism Dev Disord; 2019 Jan; 49(1):227-235. PubMed ID: 30136113
[TBL] [Abstract][Full Text] [Related]
17. Medication Use in the Management of Comorbidities Among Individuals With Autism Spectrum Disorder From a Large Nationwide Insurance Database.
Feroe AG; Uppal N; Gutiérrez-Sacristán A; Mousavi S; Greenspun P; Surati R; Kohane IS; Avillach P
JAMA Pediatr; 2021 Sep; 175(9):957-965. PubMed ID: 34097007
[TBL] [Abstract][Full Text] [Related]
18. Use of psychotropic drugs in patients with autism spectrum disorders: a systematic review.
Jobski K; Höfer J; Hoffmann F; Bachmann C
Acta Psychiatr Scand; 2017 Jan; 135(1):8-28. PubMed ID: 27624381
[TBL] [Abstract][Full Text] [Related]
19. Prescription Trends of Psychotropics in Children and Adolescents with Autism Based on Nationwide Health Insurance Data.
Hong M; Lee SY; Han J; Park JC; Lee YJ; Hwangbo R; Chang H; Cho SW; Bhang SY; Kim B; Hwang JW; Bahn GH
J Korean Med Sci; 2017 Oct; 32(10):1687-1693. PubMed ID: 28875615
[TBL] [Abstract][Full Text] [Related]
20. Psychopharmacological prescriptions for people with autism spectrum disorder (ASD): a multinational study.
Hsia Y; Wong AY; Murphy DG; Simonoff E; Buitelaar JK; Wong IC
Psychopharmacology (Berl); 2014 Mar; 231(6):999-1009. PubMed ID: 24005531
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]